Cookie Settings
We use cookies to provide an optimal experience for you. Technically required cookies are used for making shopping possible, statistics are used for anonymized Google Analytics. You can read everything in our updated privacy policy.
The ability to isolate specific immune cell populations is critical for many areas of biomedical research. Whether studying T cells, NK cells, monocytes, or broader leukocyte populations, researchers often need samples that contain minimal interference from unwanted cell types. One common challenge is the presence of B cells within mixed immune cell populations. While B cells are important components of the immune system, they are not always relevant to the objectives of a particular study.
As a result, B cell depletion has become a routine part of many cell separation workflows. Removing CD19⁺ B cells can help researchers generate cleaner non-B cell populations that are better suited for downstream analysis. This is particularly important in applications where the presence of B cells may influence cellular responses, alter population distributions, or complicate data interpretation.
pluriSpin® Human CD19⁺ Cell Depletion was developed to provide a practical solution for generating B cell-depleted populations from whole blood, buffy coat, cord blood, and related sample materials. Using a negative isolation approach, the technology removes unwanted B cells while leaving the desired cell populations untouched and available for further research.
Many immune cell studies focus on populations other than B cells. Researchers investigating T cell activation, NK cell function, monocyte biology, or broader immune responses often benefit from reducing B cell content before analysis. Cleaner non-B cell populations can provide several advantages.
When unwanted B cells are removed, researchers can focus more directly on the cell populations relevant to their study. This helps simplify data interpretation and experimental design.
Reducing B cell content increases the relative proportion of other immune cells within the sample. This can make it easier to evaluate target populations without additional enrichment steps.
B cells actively participate in immune responses through cytokine production, antigen presentation, and antibody-related activities. Removing them can help reduce variables that may influence experimental outcomes.
Cleaner cell populations often produce more predictable results across experiments, supporting greater reproducibility and confidence in the data.
These benefits explain why B cell depletion has become a common strategy in modern immunology and cell biology research.
Whole blood is one of the most frequently used sample types in research, but it is also one of the most complex.
A typical blood sample contains:
Red blood cells
Platelets
Granulocytes
Monocytes
Lymphocytes
Plasma components
Researchers attempting to isolate non-B cell populations must work within this complex cellular environment.
The large number of different cell types present in blood makes selective isolation more challenging.
Cell distributions can vary between donors and samples, affecting separation performance and consistency.
Red blood cells represent the majority of cells in whole blood and contribute to the complexity of sample processing.
Researchers often need to improve purity while maintaining acceptable recovery of the desired cells.
These challenges highlight the importance of efficient depletion strategies that simplify the generation of cleaner non-B cell populations.
Negative cell isolation is based on a simple principle: remove the unwanted cells rather than directly targeting the desired population.
Unlike positive selection methods, which capture the cells of interest, negative isolation focuses on depletion of specific cell types. The remaining cells become enriched simply because unwanted populations have been removed.
This approach offers several advantages.
The target cells remain untouched throughout the isolation process.
Untouched cells can be used in a wide variety of downstream applications without concerns related to direct labeling.
The desired population undergoes less direct handling compared with some positive selection methods.
Negative isolation can support both broad immune cell studies and highly specialized investigations.
Because of these characteristics, negative isolation remains a popular strategy for generating usable and biologically relevant cell populations.
pluriSpin® Human CD19⁺ Cell Depletion is designed to isolate pure, viable, and untouched B cell-free populations from whole blood, buffy coat, cord blood, and similar sample materials.
The technology works through selective depletion of CD19⁺ B cells while preserving the remaining immune cell populations.
Key features include:
Negative cell isolation
Untouched target populations
Compatibility with multiple blood-derived sample types
No columns required
No magnetic separation systems
No specialized instrumentation
Straightforward workflow implementation
The system is designed to fit naturally into laboratory workflows that already utilize density gradient centrifugation.
This combination of simplicity and flexibility makes it suitable for both routine and specialized applications.
The pluriSpin® workflow combines selective labeling with density gradient centrifugation to remove unwanted B cells.
The pluriSpin® suspension is added directly to the sample. During incubation, the reagent selectively associates with CD19⁺ B cells. The remaining cell populations are not targeted during this step.
The sample is gently mixed to promote efficient interaction between the depletion reagent and the target cells. This helps ensure consistent labeling throughout the sample volume.
Following incubation, the sample is layered over a density gradient medium and centrifuged. During centrifugation, the labeled B cells migrate away from the desired cell fraction and pellet with red blood cells and other unwanted components.
The enriched non-B cell population remains at the interface between the plasma and density medium. Researchers can collect this fraction for further processing.
The collected cells undergo washing steps that help remove residual contaminants and prepare the sample for downstream applications. The result is a cleaner and more defined non-B cell population ready for experimental use.
Removing B cells affects more than just the overall composition of a sample. It can significantly improve the quality, consistency, and usability of the remaining cell population, helping researchers obtain more meaningful and reliable experimental results.
Reducing unwanted B cells creates a more focused sample composition. With fewer irrelevant cells present, researchers can work with populations that better reflect the biological processes they are trying to study. This cleaner cellular environment helps reduce background noise and allows target cell populations to be examined more effectively.
Researchers can evaluate the desired cell populations with less interference from unrelated cells. Whether performing flow cytometry, functional assays, or molecular studies, a reduced B cell presence can help improve the accuracy of data collection and interpretation.
When B cells are removed, the relative abundance of non-B cell populations becomes easier to assess. This allows researchers to better characterize T cells, NK cells, monocytes, and other immune cell subsets without the influence of large numbers of unwanted cells.
A cleaner starting population can simplify both experimental design and data analysis. Researchers may spend less time compensating for mixed cell populations and more time focusing on the specific biological questions being investigated.
More consistent cell composition supports reliable results across different samples, experiments, and operators. Standardizing the starting population helps reduce variability and improves confidence in downstream findings.
Together, these benefits contribute to higher-quality research outcomes, improved workflow efficiency, and greater confidence in the interpretation of experimental data.
One of the primary benefits of the pluriSpin® approach is that the desired cells remain untouched throughout the depletion process.
Untouched cells are well suited for phenotypic analysis and population characterization.
Researchers can evaluate cellular responses without concerns related to direct cell labeling.
Maintaining native cell characteristics can be valuable for culture-based studies.
Untouched populations provide suitable starting material for RNA, DNA, and protein investigations.
Researchers studying cellular communication and immune function often prefer populations that have not been directly manipulated.
Because the cells remain available in their natural state, the enriched population can be used across a wide variety of research applications.
B cell depletion supports numerous research areas.
Researchers can focus more directly on T cell behavior, activation, and signaling.
Reducing B cell content improves the relative representation of NK cells within the sample.
Cleaner populations help support more focused studies of monocyte biology and function.
Defined cell populations simplify the analysis of immune cell distributions and phenotypes.
Researchers can evaluate cellular responses in populations that contain fewer unwanted cells.
Cleaner immune cell populations can support studies related to disease mechanisms, biomarkers, and therapeutic development.
These applications demonstrate the broad utility of B cell depletion workflows across different research disciplines.
Although pluriSpin® Human CD19⁺ Cell Depletion is designed to be straightforward, proper sample handling remains important.
Whenever possible, fresh and properly handled samples should be used.
The pluriSpin® suspension should be thoroughly resuspended before use.
Proper incubation supports efficient labeling of unwanted B cells.
Maintaining separation between the sample and density gradient medium helps optimize centrifugation performance.
Consistent washing improves sample quality and removes residual contaminants.
Attention to these details can help maximize both purity and recovery.
At pluriSelect, we focus on creating practical solutions that address real-world cell separation challenges. Our goal is to help researchers simplify workflows while maintaining high standards of quality and reproducibility.
Researchers choose our technologies because we provide:
Our products are developed to support specific cell isolation, enrichment, and depletion objectives.
We prioritize technologies that integrate naturally into existing laboratory procedures.
Products are manufactured according to strict quality standards to support consistent performance.
The pluriSpin® platform offers multiple enrichment and depletion solutions for different target populations.
We work closely with researchers to support successful implementation and long-term project success.
As a biotechnology company focused on cell and protein separation, pluriSelect continues to develop technologies that help researchers spend more time generating data and less time managing workflow challenges.
Generating cleaner non-B cell populations is an important goal in many areas of immunology and cell biology research. The presence of B cells can complicate analysis, influence experimental outcomes, and reduce the focus of downstream investigations.
pluriSpin® Human CD19⁺ Cell Depletion provides a practical solution through selective negative isolation. By removing unwanted B cells while leaving the remaining immune cell populations untouched, the technology helps researchers generate highly enriched non-B cell fractions suitable for a wide range of applications.
Its compatibility with whole blood, buffy coat, and cord blood, combined with a straightforward density-gradient-based workflow, makes it an accessible and effective option for laboratories seeking cleaner cell populations. For researchers aiming to improve sample quality while maintaining workflow simplicity, pluriSpin® Human CD19⁺ Cell Depletion offers a reliable approach to modern cell separation.